GS1 US Appoints Greg Bylo Vice-President of Healthcare
PTSM: Pharmaceutical Technology Sourcing and Management
Bylo has been selected to lead the GS1 Healthcare US Industry Initiative, focused on driving adoption and usage of GS1 Standards in healthcare.
GS1 US has appointed Greg Bylo vice-president, healthcare to lead GS1 Healthcare US, an industry-wide initiative combining pharmaceutical, medical device, provider, and patient care professionals that are collaborating to drive the adoption of GS1 Standards for improved patient safety and supply chain performance in the healthcare industry. The initiative is also focused on GS1 Standards implementation to support the FDA Drug Supply Chain Security Act and Unique Device Identification (UDI) Rule requirements.
Prior to joining GS1 US, Bylo was the senior director of global supply chain support services at Integra Life Sciences where he was responsible for supply chain planning of global products. He also spent more than 15 years at Becton Dickinson leading sales and operations planning and supply chain planning teams that were focused on decreasing organizational supply chain costs and increasing customer engagement.
Bylo earned a bachelor of science degree in mechanical engineering and material science from the University of Connecticut. He is a Certified Quality Engineer from the American Society of Quality, a member of the Association for Planning and Inventory Control and a certified Six Sigma Green Belt.
Source: GS1
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
